馬偕醫學大學機構典藏(MacKay Medical University Institutional Repository):Item 987654321/2771
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 1671/1770
造访人次 : 4341744      在线人数 : 237
RC Version 5.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 进阶搜寻

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://140.112.115.32:8080/ir/handle/987654321/2771

题名: Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo
作者: Kuan H. Lin;Jinn R. Kuo;Wan J. Lu;Chi L. Chung;Duen S. Chou;Shih Y. Huang;Hsiu C. Lee;Joen R. Sheu
贡献者: 視光學系
关键词: Hinokitiol;Hydroxyl radical;MAPK;Occlusion time;Platelet activation;PLCγ2
日期: 2013-05-01
上传时间: 2025-08-01 15:07:02 (UTC+8)
摘要: Hinokitiol is a tropolone-related bioactive compound that has been used in hair tonics, cosmetics, and food as an antimicrobial agent. Recently, hinokitiol has attracted considerable interest because of its anticancer activities. Platelet activation plays a crucial role in atherothrombotic processes. We examined the effects of hinokitiol treatment on platelet activation using human platelets. In the present study, hinokitiol (1 and 2 μM) inhibited the collagen-induced aggregation of human platelets, but did not inhibit the activation of platelets by other agonists, including thrombin, arachidonic acid, and ADP. Hinokitiol inhibited the phosphorylation of phospholipase C (PLC)γ2, protein kinase C (PKC), mitogen-activated protein kinases (MAPKs), and Akt in collagen-activated human platelets, and significantly reduced intracellular calcium mobilization and hydroxyl radical (OHradical dot) formation. Hinokitiol also reduced the PKC activation and platelet aggregation stimulated by PDBu. In addition, hinokitiol significantly prolonged thrombogenesis in mice. Hinokitiol did not influence the binding of a fluorescent triflavin probe to the αIIbβ3 integrin on platelet membrane, and neither ODQ nor SQ22536 significantly reversed the hinokitiol-mediated inhibition of platelet aggregation. In conclusion, hinokitiol may inhibit platelet activation by inhibiting the PLCγ2-PKC cascade and hydroxyl radical formation, followed by suppressing the activation of MAPKs and Akt. Our study suggests that hinokitiol may represent a potential therapeutic agent for the prevention or treatment of thromboembolic disorders.
關聯: Biochemical Pharmacology, 85(10), 1478-1485. https://doi.org/10.1016/j.bcp.2013.02.027
显示于类别:[視光學系] 期刊論文

文件中的档案:

档案 大小格式浏览次数
index.html0KbHTML21检视/开启


在MMUIR中所有的数据项都受到原著作权保护.

 


DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈